Skip to content
Dx

ICD-10-PCS 2027 procedure code

XW0336CIntroduction of Landiolol Antiarrhythmic into Peripheral Vein, Percutaneous Approach, New Technology Group 12

✓ Valid for 2027New for 2027

Short description: Introduce Landiolol in Periph Vein, Perc, New Tech 12

Code last changed in FY2027 (effective October 1, 2026). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About XW0336C

XW0336C is the ICD-10-PCS code for a introduction procedure on the peripheral vein using a percutaneous approach with landiolol antiarrhythmic (qualifier: new technology group 12). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

For a different body part, codes include XW0436C (central vein).

With a different device, use XW0337C (tabelecleucel immunotherapy).

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It was added in FY2027, effective October 1, 2026.

What each character means

1. Section
XNew Technology
2. Body System
WAnatomical Regions
3. Operation
0Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4. Body Part
3Peripheral Vein
5. Approach
3Percutaneous

Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure

6. Device / Substance / Technology
6Landiolol Antiarrhythmic

Includes: RAPIBLYK(tm)

7. Qualifier
CNew Technology Group 12

Other versions of this procedure

Different body part

Different device / substance / technology

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2027 (effective 10/1/2026): Added

Common questions about XW0336C

Is XW0336C a valid ICD-10-PCS code for 2027?

Yes. XW0336C is valid for inpatient procedures from October 1, 2026 through September 30, 2027.